Ultrastructural evidence for persistent
✍
Bruce D. Cheson; Dr. Daniel O. Clegg; Farhad Moatamed
📂
Article
📅
1986
🏛
John Wiley and Sons
🌐
English
⚖ 542 KB
Patients receiving gold therapy for rheumatoid arthritis or other inflammatory disorders may develop aplastic anemia, thrombocytopenia, agranulocytosis, proteinuria, glomerulopathy , dermatitis, and stomatitis (1-3). We describe a patient with chronic juvenile rheumatoid arthritis who developed apla